20 min listen
CBD for Neuropathic Pain Clinical Trial Results with Debra Kimless, MD
CBD for Neuropathic Pain Clinical Trial Results with Debra Kimless, MD
ratings:
Length:
20 minutes
Released:
Apr 21, 2021
Format:
Podcast episode
Description
Dr. Debra Kimless is the CMO of Pure Green Pharmaceuticals, where she oversees clinical medical testing, patient and physician educational programs, and medical product development. Deb and her team recently published an open-label clinical trial for treating diabetic neuropathic pain with a water-soluble CBD tablet.
In our conversation we discuss:
Results from her clinical trial for treating diabetic neuropathic pain with CBDWhat makes diabetic neuropathic pain a good candidate for cannabinoid therapies Comparing the adverse effects of standard DNP treatments to CBD The advantages of delivering cannabinoids via a water-soluble tablet Why there are not more clinical studies into cannabinoid therapies Tools consumers can use to identify proper clinical trials
Thanks to This Episode's Sponsor: Pure Green Pharmaceuticals
Pure Green Pharmaceuticals manufactures the finest medical products, using selected cannabinoid molecules as primary ingredients. Their goal is to relieve human and animal suffering through the use of purified cannabis.
Learn more at pgpharma.co
Additional Resources
The Effects of Cannabidiol-Based Sublingual Tablets on Diabetic Neuropathic PainAnalgesic Alternative: How Non-intoxicating Cannabinoids Can Relieve Pain - Debra Kimless, MD CannMed 2018Case Presentations of Cancer Patients Treated with Cannabis Oil - Debra Kimless, MD CannMed 2017
In our conversation we discuss:
Results from her clinical trial for treating diabetic neuropathic pain with CBDWhat makes diabetic neuropathic pain a good candidate for cannabinoid therapies Comparing the adverse effects of standard DNP treatments to CBD The advantages of delivering cannabinoids via a water-soluble tablet Why there are not more clinical studies into cannabinoid therapies Tools consumers can use to identify proper clinical trials
Thanks to This Episode's Sponsor: Pure Green Pharmaceuticals
Pure Green Pharmaceuticals manufactures the finest medical products, using selected cannabinoid molecules as primary ingredients. Their goal is to relieve human and animal suffering through the use of purified cannabis.
Learn more at pgpharma.co
Additional Resources
The Effects of Cannabidiol-Based Sublingual Tablets on Diabetic Neuropathic PainAnalgesic Alternative: How Non-intoxicating Cannabinoids Can Relieve Pain - Debra Kimless, MD CannMed 2018Case Presentations of Cancer Patients Treated with Cannabis Oil - Debra Kimless, MD CannMed 2017
Released:
Apr 21, 2021
Format:
Podcast episode
Titles in the series (97)
Tissue Culture Propagation with Mark Jordan: On this episode, we talked with tissue culture expert, Mark Jordan. Mark is currently the Chief Executive Officer at Minibis headquartered in Longmont, CO, where he started a tissue culture lab dedicated to Cannabis research and development. by CannMed Coffee Talk